Food and Drug Administration (FDA) officials rejected the notion of a ban on cough and cold medications for children at a public hearing, the Associated Press reports.
Food and Drug Administration (FDA) officials rejected the notion of a ban on cough and cold medications for children at a public hearing, the Associated Press (AP) reports.
The officials stated they needed more data on whether such over-the-counter medicine are safe and effective for children ages 2 to 6. The FDA also stated a concern that a ban would lead to parents giving adult cough and cold drugs to their children
However, pediatricians' groups have been urging the FDA to recall over-the-counter cough and cold medications for children younger than 6. Earlier this year, the FDA issued a statement against the use of over-the-counter cold medicine to pediatric patients younger than 2.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.